{
    "root": "3df1272e-4722-4152-abae-b5a635bb693b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "VOQUEZNA DUAL PAK",
    "value": "20250514",
    "ingredients": [],
    "indications": {
        "text": "voquezna triple pak , co-packaged product containing vonoprazan , potassium-competitive acid blocker ( pcab ) , amoxicillin , penicillin class antibacterial , clarithromycin , macrolide antimicrobial , indicated treatment helicobacter pylori ( h. pylori ) infection adults . ( 1.1 ) voquezna dual pak , co-packaged product containing vonoprazan , pcab , amoxicillin , penicillin class antibacterial , indicated treatment h. pylori infection adults . ( 1.1 ) reduce development drug-resistant bacteria maintain effectiveness voquezna triple pak , voquezna dual pak antibacterial drugs , voquezna triple pak voquezna dual pak used treat prevent infections proven strongly suspected caused bacteria . ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "voquezna triple pak : recommended vonoprazan 20 mg plus amoxicillin 1,000 mg plus clarithromycin 500 mg , given twice daily ( morning evening , 12 hours apart ) , without food , 14 days . ( 2.1 ) voquezna dual pak : recommended vonoprazan 20 mg twice daily ( morning evening ) plus amoxicillin 1,000 mg , three times day ( morning , mid-day , evening ) , without food , 14 days . ( 2.2 ) full prescribing information recommended patients renal hepatic impairment . ( 2.3 , 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "voquezna triple pak co-package containing : vonoprazan tablets , 20 mg : pale red , oval , film-coated tablets debossed v20 one side plain side . amoxicillin capsules , 500 mg : yellow , opaque , hard gelatin capsules imprinted amox 500 one side gg 849 side . clarithromycin tablets , 500 mg : white , oval , film-coated tablets debossed gg c9 one side plain side . vonoprazan tablets , amoxicillin capsules , clarithromycin tablets supplied separate blister cavities within blister card . unit carton ( ndc 81520-255-14 ) contains 56 tablets 56 capsules divided 14 daily dose blister cards . daily blister card contains two vonoprazan tablets ( 20 mg ) , four amoxicillin capsules ( 500 mg ) , two clarithromycin tablets ( 500 mg ) , indicates tablets capsules need taken morning evening .",
    "adverseReactions": "voquezna triple pak voquezna dual pak : known hypersensitivity vonoprazan , amoxicillin beta-lactams , clarithromycin macrolide antimicrobial component voquezna triple pak . ( 4.1 ) known hypersensitivity vonoprazan , amoxicillin beta-lactams component voquezna dual pak . ( 4.1 ) rilpivirine-containing products . ( 4.1 ) voquezna triple pak due clarithromycin component : pimozide . ( 4.2 ) lomitapide , lovastatin , simvastatin . ( 4.2 ) ergot alkaloids ( ergotamine dihydroergotamine ) . ( 4.2 ) colchicine renal hepatic impairment . ( 4.2 ) history cholestatic jaundice/hepatic dysfunction clarithromycin . ( 4.2 ) lurasidone . ( 4.2 )",
    "indications_original": "VOQUEZNA TRIPLE PAK, is a co-packaged product containing vonoprazan, a potassium-competitive acid blocker (PCAB), amoxicillin, a penicillin class antibacterial, and clarithromycin, a macrolide antimicrobial, indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults. ( 1.1 ) VOQUEZNA DUAL PAK, is a co-packaged product containing vonoprazan, a PCAB, and amoxicillin, a penicillin class antibacterial, indicated for the treatment of H. pylori infection in adults. ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK and other antibacterial drugs, VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.2 )",
    "contraindications_original": "VOQUEZNA TRIPLE PAK : The recommended dosage is vonoprazan 20 mg plus amoxicillin 1,000 mg plus clarithromycin 500 mg, each given twice daily (morning and evening, 12 hours apart), with or without food, for 14 days. ( 2.1 ) VOQUEZNA DUAL PAK : The recommended dosage is vonoprazan 20 mg twice daily (morning and evening) plus amoxicillin 1,000 mg, three times a day (morning, mid-day, and evening), with or without food, for 14 days. ( 2.2 ) See full prescribing information for the recommended dosage for patients with renal or hepatic impairment. ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "VOQUEZNA TRIPLE PAK is a co-package containing:\n                  \n                     Vonoprazan Tablets, 20 mg: pale red, oval, film-coated tablets debossed V20 on one side and plain on the other side.\n                     Amoxicillin Capsules, 500 mg: yellow, opaque, hard gelatin capsules imprinted with AMOX 500 on one side and GG 849 on the other side.\n                     Clarithromycin Tablets, 500 mg: white, oval, film-coated tablets debossed GG C9 on one side and plain on the other side.\n                  \n                  Vonoprazan tablets, amoxicillin capsules, and clarithromycin tablets are supplied in separate blister cavities within the same blister card.\n                  Each unit of use carton (NDC 81520-255-14) contains 56 tablets and 56 capsules divided into 14 daily dose blister cards.\n                  Each daily blister card contains two vonoprazan tablets (20 mg each), four amoxicillin capsules (500 mg each), and two clarithromycin tablets (500 mg each), and indicates which tablets and capsules need to be taken in the morning and evening.",
    "adverseReactions_original": "VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK : Known hypersensitivity to vonoprazan, amoxicillin or any other beta-lactams, clarithromycin or any other macrolide antimicrobial or any component of VOQUEZNA TRIPLE PAK. ( 4.1 ) Known hypersensitivity to vonoprazan, amoxicillin or any other beta-lactams or any component of VOQUEZNA DUAL PAK. ( 4.1 ) Rilpivirine-containing products. ( 4.1 ) VOQUEZNA TRIPLE PAK Due to the Clarithromycin Component : Pimozide. ( 4.2 ) Lomitapide, lovastatin, and simvastatin. ( 4.2 ) Ergot alkaloids (ergotamine or dihydroergotamine). ( 4.2 ) Colchicine in renal or hepatic impairment. ( 4.2 ) History of cholestatic jaundice/hepatic dysfunction with use of clarithromycin. ( 4.2 ) Lurasidone. ( 4.2 )",
    "drug": [
        {
            "name": "VOQUEZNA DUAL PAK"
        }
    ]
}